{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:10:07Z","timestamp":1773184207682,"version":"3.50.1"},"reference-count":46,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/ijo.2015.3047","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T08:37:52Z","timestamp":1434098272000},"page":"668-678","source":"Crossref","is-referenced-by-count":9,"title":["Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA"],"prefix":"10.3892","volume":"47","author":[{"given":"YANG","family":"GAO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAYUN","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XINYU","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAIXING","family":"AI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QI","family":"ZHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHOU","family":"YUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"key":"key20180107190907_b1-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107190907_b2-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"10223","DOI":"10.3748\/wjg.v20.i30.10223","article-title":"Current management of hepatocellular carcinoma","volume":"20","author":"Tabrizian","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20180107190907_b3-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"key20180107190907_b4-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/1751-2980.12038","article-title":"Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study","volume":"14","author":"Bai","year":"2013","journal-title":"J Dig Dis"},{"key":"key20180107190907_b5-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejim.2014.03.001","article-title":"Multimodal treatment of hepatocellular carcinoma","volume":"25","author":"Graf","year":"2014","journal-title":"Eur J Intern Med"},{"key":"key20180107190907_b6-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"key20180107190907_b7-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/gt.2011.16","article-title":"Cancer targeting gene-viro-therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene","volume":"18","author":"Cao","year":"2011","journal-title":"Gene Ther"},{"key":"key20180107190907_b8-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/hum.2010.219","article-title":"Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma","volume":"22","author":"Wei","year":"2011","journal-title":"Hum Gene Ther"},{"key":"key20180107190907_b9-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.cgt.7701105","article-title":"A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes","volume":"15","author":"Hu","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"key20180107190907_b10-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425247.2014.874414","article-title":"Utilizing adenovirus vectors for gene delivery in cancer","volume":"11","author":"Kasala","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"key20180107190907_b11-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1745-7270.2005.00087.x","article-title":"Targeting gene-virotherapy for cancer","volume":"37","author":"Liu","year":"2005","journal-title":"Acta Biochim Biophys Sin"},{"key":"key20180107190907_b12-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1158\/1078-0432.CCR-03-0122","article-title":"A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells","volume":"10","author":"Huang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107190907_b13-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1078-0432.CCR-04-0060","article-title":"Targeting cancer with telomerase: commentary re Q. Huang et al:, a novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells. Clin Cancer Res, 10: 1439\u20131445, 2004","volume":"10","author":"Hahn","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107190907_b14-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00004836-200012000-00007","article-title":"Clinical characteristics and prognosis of hepatocellular carcinoma: Analysis based on serum alpha-fetoprotein levels","volume":"31","author":"Tangkijvanich","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"key20180107190907_b15-ijo-47-02-0668","first-page":"6428","article-title":"A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin","volume":"61","author":"Li","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107190907_b16-ijo-47-02-0668","first-page":"3016","article-title":"Gene therapy targeting for hepatocellular carcinoma: Selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter","volume":"61","author":"Ido","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107190907_b17-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/1078-0432.CCR-10-0664","article-title":"A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas","volume":"16","author":"Kwon","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107190907_b18-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/sj.gt.3301987","article-title":"Telomerase-dependent oncolytic adenovirus for cancer treatment","volume":"10","author":"Huang","year":"2003","journal-title":"Gene Ther"},{"key":"key20180107190907_b19-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00432-010-0806-y","article-title":"Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma","volume":"136","author":"Yuan","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107190907_b20-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2004.03.029","article-title":"Focal adhesion kinase is over-expressed in hepatocellular carcinoma and can be served as an independent prognostic factor","volume":"41","author":"Fujii","year":"2004","journal-title":"J Hepatol"},{"key":"key20180107190907_b21-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/187152010794728648","article-title":"Focal adhesion kinase as a cancer therapy target","volume":"10","author":"Golubovskaya","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180107190907_b22-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/v6020856","article-title":"Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo","volume":"6","author":"He","year":"2014","journal-title":"Viruses"},{"key":"key20180107190907_b23-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vascn.2013.09.003","article-title":"Comparison of PrestoBlue and MTT assays of cellular viability in the assessment of anti-proliferative effects of plant extracts on human endothelial cells","volume":"69","author":"Boncler","year":"2014","journal-title":"J Pharmacol Toxicol Methods"},{"key":"key20180107190907_b24-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12975-014-0325-2","article-title":"Clinically relevant reperfusion in acute ischemic stroke: MTT performs better than Tmax and TTP","volume":"5","author":"Ford","year":"2014","journal-title":"Transl Stroke Res"},{"key":"key20180107190907_b25-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3892\/ijmm.2012.1077","article-title":"Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma","volume":"30","author":"Liu","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180107190907_b26-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-1046-03","article-title":"Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma","volume":"10","author":"Itoh","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107190907_b27-ijo-47-02-0668","first-page":"4200","article-title":"The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts","volume":"59","author":"Yu","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107190907_b28-ijo-47-02-0668","first-page":"4663","article-title":"Novel oncolytic adenoviruses targeted to melanoma: Specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer\/promoter","volume":"62","author":"Nettelbeck","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107190907_b29-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/1078-0432.CCR-08-2008","article-title":"Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo","volume":"15","author":"Leitner","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107190907_b30-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2012.09.003","article-title":"Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo","volume":"328","author":"Dong","year":"2013","journal-title":"Cancer Lett"},{"key":"key20180107190907_b31-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1007\/s13277-014-2353-7","article-title":"Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol"},{"key":"key20180107190907_b32-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1582-4934.2011.01396.x","article-title":"A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect","volume":"16","author":"Liu","year":"2012","journal-title":"J Cell Mol Med"},{"key":"key20180107190907_b33-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1007\/s11033-013-2638-8","article-title":"Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice","volume":"40","author":"He","year":"2013","journal-title":"Mol Biol Rep"},{"key":"key20180107190907_b34-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/hep.27402","article-title":"FAK is required for c-Met\/beta-catenin-driven hepatocarcinogenesis","volume":"61","author":"Shang","year":"2014","journal-title":"Hepatology"},{"key":"key20180107190907_b35-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.4395","article-title":"Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways","volume":"234","author":"Dai","year":"2014","journal-title":"J Pathol"},{"key":"key20180107190907_b36-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1871520611313040004","article-title":"Upregulation of focal adhesion kinase by 14-3-3\u025b via NF\u03baB activation in hepatocellular carcinoma","volume":"13","author":"Ko","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180107190907_b37-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12032-008-9137-0","article-title":"Overexpression and significance of focal adhesion kinase in hepatocellular carcinoma and its relationship with HBV infection","volume":"26","author":"Cai","year":"2009","journal-title":"Med Oncol"},{"key":"key20180107190907_b38-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1349-7006.2006.00234.x","article-title":"Therapeutic potential of RNA interference against cancer","volume":"97","author":"Takeshita","year":"2006","journal-title":"Cancer Sci"},{"key":"key20180107190907_b39-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.cr.7310108","article-title":"Targeting gene-virotherapy of cancer and its prosperity","volume":"16","author":"Liu","year":"2006","journal-title":"Cell Res"},{"key":"key20180107190907_b40-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1093\/nar\/gkg409","article-title":"Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2\u2032-O-methyl RNA, phosphorothioates and small interfering RNA","volume":"31","author":"Gr\u00fcnweller","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"key20180107190907_b41-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-013-0019-4","article-title":"RNA interference in the treatment of colon cancer","volume":"27","author":"Prados","year":"2013","journal-title":"BioDrugs"},{"key":"key20180107190907_b42-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3892\/or.2012.2196","article-title":"siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells","volume":"29","author":"Liu","year":"2013","journal-title":"Oncol Rep"},{"key":"key20180107190907_b43-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hep.20203","article-title":"An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice","volume":"39","author":"Pei","year":"2004","journal-title":"Hepatology"},{"key":"key20180107190907_b44-ijo-47-02-0668","first-page":"1035","article-title":"Potent anti-hepatoma efficacy of HCCS1 via dual tumor-targeting gene-virotherapy strategy","volume":"20","author":"Zhang","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180107190907_b45-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/08941939.2013.873098","article-title":"Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma","volume":"27","author":"Wu","year":"2014","journal-title":"J Invest Surg"},{"key":"key20180107190907_b46-ijo-47-02-0668","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.4161\/cbt.7.10.6539","article-title":"siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma","volume":"7","author":"Guo","year":"2008","journal-title":"Cancer Biol Ther"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3047\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T19:13:18Z","timestamp":1515352398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,6,12]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/ijo.2015.3047"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3047","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}